Page last updated: 2024-09-03

3-(2,2,2-trimethylhydrazine)propionate and zidovudine

3-(2,2,2-trimethylhydrazine)propionate has been researched along with zidovudine in 2 studies

Compound Research Comparison

Studies
(3-(2,2,2-trimethylhydrazine)propionate)
Trials
(3-(2,2,2-trimethylhydrazine)propionate)
Recent Studies (post-2010)
(3-(2,2,2-trimethylhydrazine)propionate)
Studies
(zidovudine)
Trials
(zidovudine)
Recent Studies (post-2010) (zidovudine)
2513510510,1801,3991,188

Protein Interaction Comparison

ProteinTaxonomy3-(2,2,2-trimethylhydrazine)propionate (IC50)zidovudine (IC50)
Thymidine kinase, cytosolicHomo sapiens (human)3
Reverse transcriptase/RNaseH Human immunodeficiency virus 10.6633
Protease Human immunodeficiency virus 10.015

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gordjushina, V; Isajevs, S; Kalvinsh, I; Klusa, V; Kratovska, A; Pupure, J; Rumaks, J; Svirskis, S; Taivans, I; Viksna, L1
Isajevs, S; Kalvinsh, I; Klusa, V; Pupure, J; Rumaks, J; Skapare, E; Svirina, D; Svirskis, S1

Other Studies

2 other study(ies) available for 3-(2,2,2-trimethylhydrazine)propionate and zidovudine

ArticleYear
Protection of azidothymidine-induced cardiopathology in mice by mildronate, a mitochondria-targeted drug.
    Basic & clinical pharmacology & toxicology, 2006, Volume: 99, Issue:4

    Topics: Animals; Cardiovascular Agents; Disease Models, Animal; Heart Diseases; Methylhydrazines; Mice; Mice, Inbred ICR; Mitochondria; Zidovudine

2006
Neuroprotective properties of mildronate, a mitochondria-targeted small molecule.
    Neuroscience letters, 2010, Feb-12, Volume: 470, Issue:2

    Topics: Animals; Anti-HIV Agents; Brain; Caspase 3; Cellular Apoptosis Susceptibility Protein; Disease Models, Animal; Electron Transport Complex IV; Glial Fibrillary Acidic Protein; Lymphocytes; Male; Methylhydrazines; Mice; Mice, Inbred Strains; Neuroprotective Agents; Neurotoxicity Syndromes; Nitric Oxide Synthase Type II; Zidovudine

2010